AQR Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Sell |
17,409
-22,678
| -57% | -$1.25M | ﹤0.01% | 2227 |
|
|
2025
Q1 | $1.94M | Sell |
40,087
-110,010
| -73% | -$5.32M | ﹤0.01% | 1627 |
|
|
2024
Q4 | $5.79M | Buy |
150,097
+12,926
| +9% | +$499K | 0.01% | 1038 |
|
|
2024
Q3 | $6.17M | Buy |
137,171
+112,116
| +447% | +$5.05M | 0.01% | 963 |
|
|
2024
Q2 | $868K | Sell |
25,055
-55,952
| -69% | -$1.94M | ﹤0.01% | 1818 |
|
|
2024
Q1 | $2.34M | Buy |
81,007
+71,665
| +767% | +$2.07M | ﹤0.01% | 1343 |
|
|
2023
Q4 | $214K | Sell |
9,342
-1,124
| -11% | -$25.8K | ﹤0.01% | 2191 |
|
|
2023
Q3 | $175K | Sell |
10,466
-653
| -6% | -$10.9K | ﹤0.01% | 2161 |
|
|
2023
Q2 | $307K | Buy |
+11,119
| New | +$307K | ﹤0.01% | 1929 |
|
|
2023
Q1 | – | Sell |
-40,970
| Closed | -$447K | – | 2236 |
|
|
2022
Q4 | $447K | Sell |
40,970
-73,718
| -64% | -$804K | ﹤0.01% | 1850 |
|
|
2022
Q3 | $967K | Buy |
+114,688
| New | +$967K | ﹤0.01% | 1533 |
|
|
2022
Q1 | – | Sell |
-15,177
| Closed | -$519K | – | 2280 |
|
|
2021
Q4 | $519K | Sell |
15,177
-26,500
| -64% | -$906K | ﹤0.01% | 1812 |
|
|
2021
Q3 | $739K | Buy |
41,677
+15,069
| +57% | +$267K | ﹤0.01% | 1703 |
|
|
2021
Q2 | $1.19M | Sell |
26,608
-3,779
| -12% | -$170K | ﹤0.01% | 1504 |
|
|
2021
Q1 | $787K | Buy |
30,387
+6,964
| +30% | +$180K | ﹤0.01% | 1656 |
|
|
2020
Q4 | $472K | Buy |
23,423
+623
| +3% | +$12.6K | ﹤0.01% | 1812 |
|
|
2020
Q3 | $446K | Buy |
+22,800
| New | +$446K | ﹤0.01% | 1776 |
|
|
2020
Q2 | – | Sell |
-11,347
| Closed | -$80K | – | 2144 |
|
|
2020
Q1 | $80K | Sell |
11,347
-11,340
| -50% | -$80K | ﹤0.01% | 1982 |
|
|
2019
Q4 | $160K | Hold |
22,687
| – | – | ﹤0.01% | 2038 |
|
|
2019
Q3 | $272K | Buy |
+22,687
| New | +$272K | ﹤0.01% | 1932 |
|